135 related articles for article (PubMed ID: 15838257)
1. Amiodarone acutely inhibits vascular activity of endothelin-converting enzymes.
Traupe T; Lang M; Ortmann J; Keller M; Fojtu E; Vetter W; Barton M
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S113-6. PubMed ID: 15838257
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic ethanol consumption on endothelin-1 generation and conversion of exogenous big-endothelin-1 by the rat carotid artery.
Tirapelli CR; Casolari DA; Yogi A; Tostes RC; Legros E; Lanchote VL; Uyemura SA; de Oliveira AM
Alcohol; 2007 Mar; 41(2):77-85. PubMed ID: 17466482
[TBL] [Abstract][Full Text] [Related]
3. Increased endothelial exocytosis and generation of endothelin-1 contributes to constriction of aged arteries.
Goel A; Su B; Flavahan S; Lowenstein CJ; Berkowitz DE; Flavahan NA
Circ Res; 2010 Jul; 107(2):242-51. PubMed ID: 20522806
[TBL] [Abstract][Full Text] [Related]
4. CGS 35601 and its orally active prodrug CGS 37808 as triple inhibitors of endothelin-converting enzyme-1, neutral endopeptidase 24.11, and angiotensin-converting enzyme.
Trapani AJ; Beil ME; Bruseo CW; Savage P; Firooznia F; Jeng AY
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S211-5. PubMed ID: 15838282
[TBL] [Abstract][Full Text] [Related]
5. Increased endothelin-1 reactivity and endothelial dysfunction in carotid arteries from rats with hyperhomocysteinemia.
de Andrade CR; Leite PF; Montezano AC; Casolari DA; Yogi A; Tostes RC; Haddad R; Eberlin MN; Laurindo FR; de Souza HP; Corrêa FM; de Oliveira AM
Br J Pharmacol; 2009 Jun; 157(4):568-80. PubMed ID: 19371338
[TBL] [Abstract][Full Text] [Related]
6. The peptidase inhibitor CGS-26303 increases endothelin converting enzyme-1 expression in endothelial cells through accumulation of big endothelin-1.
Raoch V; Martinez-Miguel P; Arribas-Gomez I; Rodriguez-Puyol M; Rodriguez-Puyol D; Lopez-Ongil S
Br J Pharmacol; 2007 Oct; 152(3):313-22. PubMed ID: 17643133
[TBL] [Abstract][Full Text] [Related]
7. CGS 26303 upregulates mRNA expression of heme oxygenase-1 in brain tissue of rats subjected to experimental subarachnoid hemorrhage.
Yen CP; Chen SC; Lin TK; Wu SC; Chang CY; Lue SI; Jeng AY; Kassell NF; Kwan AL
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S474-8. PubMed ID: 15838352
[TBL] [Abstract][Full Text] [Related]
8. Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction of rabbit basilar artery.
Zimmermann M; Jung C; Raabe A; Spanehl O; Seifert V
Acta Neurochir Suppl; 2001; 77():73-5. PubMed ID: 11563313
[No Abstract] [Full Text] [Related]
9. Diabetes-associated changes and role of N epsilon-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction.
Matsumoto T; Ozawa Y; Taguchi K; Kobayashi T; Kamata K
Peptides; 2010 Feb; 31(2):346-53. PubMed ID: 19962413
[TBL] [Abstract][Full Text] [Related]
10. Big endothelin analogues with inhibitory activity on endothelin-converting enzyme-1.
Takayanagi R; Liu W; Ito T; Ohnaka K; Nawata H
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S62-3. PubMed ID: 9595401
[TBL] [Abstract][Full Text] [Related]
11. Alternative pathway to endothelin-converting enzyme for the synthesis of endothelin in human blood vessels.
Maguire J; Davenport AP
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S27-9. PubMed ID: 15838298
[TBL] [Abstract][Full Text] [Related]
12. Evidence for functional endothelin-converting enzyme activity in isolated rat basilar artery: effect of inhibitors.
Vatter H; Schilling L; Schmiedek P; Ehrenreich H
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S64-7. PubMed ID: 9595402
[TBL] [Abstract][Full Text] [Related]
13. Identification and partial purification of a thiol endothelin-converting enzyme from porcine aortic endothelial cells.
Deng Y; Savage P; Shetty SS; Martin LL; Jeng AY
J Biochem; 1992 Mar; 111(3):346-51. PubMed ID: 1587796
[TBL] [Abstract][Full Text] [Related]
14. Expression of endothelin-converting enzyme in both neuroblastoma and glial cell lines and its localization in rat hippocampus.
Barnes K; Walkden BJ; Wilkinson TC; Turner AJ
J Neurochem; 1997 Feb; 68(2):570-7. PubMed ID: 9003042
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-converting enzyme and its in vitro and in vivo inhibition.
Yano M; Okada K; Takada J; Hioki Y; Matsuyama K; Fukuroda T; Noguchi K; Nishikibe M; Ikemoto F
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S26-8. PubMed ID: 1725349
[TBL] [Abstract][Full Text] [Related]
16. Arrhythmogenic effects induced by coronary conversion of pulmonary big endothelin to endothelin: aggravation of this phenomenon in heritable hyperlipidemia.
Alexiou K; Dschietzig T; Simsch O; Laule M; Hundertmark J; Baumann G; Stangl K
J Am Coll Cardiol; 1998 Nov; 32(6):1773-8. PubMed ID: 9822108
[TBL] [Abstract][Full Text] [Related]
17. Big ET-1 processing into vasoactive peptides in arteries and veins.
Watts SW; Thakali K; Smark C; Rondelli C; Fink GD
Vascul Pharmacol; 2007; 47(5-6):302-12. PubMed ID: 17904426
[TBL] [Abstract][Full Text] [Related]
18. Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase.
Eto M; Barandiér C; Rathgeb L; Kozai T; Joch H; Yang Z; Lüscher TF
Circ Res; 2001 Sep; 89(7):583-90. PubMed ID: 11577023
[TBL] [Abstract][Full Text] [Related]
19. Chronic vasopeptidase inhibition restores endothelin-converting enzyme activity and normalizes endothelin levels in salt-induced hypertension.
Quaschning T; d'Uscio LV; Shaw S; Viswambharan H; Ruschitzka FT; Lüscher TF
Nephrol Dial Transplant; 2001 Jun; 16(6):1176-82. PubMed ID: 11390717
[TBL] [Abstract][Full Text] [Related]
20. [D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.
Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
Neurosurg Rev; 2003 May; 26(2):125-32. PubMed ID: 12962299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
